FREE Case Review (866) 588-0600

Onfi Lawsuit

Onfi Lawsuits are currently being investigated for users of the drug who developed serious skin reactions. In December 2013, the U.S. Food & Drug Administration warned that Onfi (clobazam) had been linked to Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), life-threatening diseases of the skin. As a result of these problems, the FDA has approved changes to the Onfi warning label, as well as to the patient Medication Guide describing the risk of severe skin reactions.

Free Onfi Lawsuit Evaluation: If you or a loved one developed Stevens-Johnson syndrome or toxic epidermal necrolysis after taking Onfi, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Onfi and we can help.

Onfi Skin Reactions

The skin reactions associated with Onfi, Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), have the ability to occur at any time during treatment with the drug. However, the likelihood of developing SJS or TEN is greater during the first two months after beginning a regimen, or when Onfi is discontinued and then restarted. All complications linked to Onfi have required emergency hospitalization, one case resulted in blindness, and one patient died from their reaction to the medication.

Symptoms of Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis

SJS is a severe, potentially fatal skin disease in which cell death causes the epidermis to separate from the dermis. TEN, another form of SJS, is a condition that occurs when the top layer of skin detaches from the lower layers of skin all over the body. Although a large number of cases of these diseases have no known cause, many have been attributed to dangerous drug interactions. Signs and symptoms of SJS/TEN may include:

  • face or stomach rash
  • blisters around the eyes, mouth or vaginal areas
  • layers of peeling skin
  • burned skin
  • severe infection

The first line of treatment for SJS/TEN usually involves the identification and proper diagnosis of the condition. Since these skin reactions have been linked to Onfi, it is important to identify drug treatments that have been initiated prior to the onset of symptoms. If Onfi has been identified as the likely cause of the disease, the medication should be discontinued immediately in favor of another treatment with fewer potential serious side effects.

What is Onfi?

Manufactured and marketed by Lundbeck, Onfi (generic: clobazam) is an FDA-approved benzodiazepine medication designed to be used in conjunction with other drugs to treat seizures associated with a type of epilepsy known as Lennox-Gastaut Syndrome. Clobazam, the main active ingredient contained in Onfi, was first synthesized more than four decades ago. Based on the results of a pair of clinical trials, including the largest study of patients with Lennox-Gastaut Syndrome, Onfi was cleared for sale on the U.S. market in 2011. Since then, over 150,000 prescriptions have been written for Onfi in the United States.

FDA Recommendation on Onfi

The FDA is advising patients who are taking Onfi to consult their physician immediately if they develop a rash, blistering or peeling of the skin, sores in the mouth, or hives. Healthcare professionals should discontinue use of Onfi and consider an alternate therapy at the first sign of these symptoms, unless the reaction is clearly not related to the drug. Patients should not stop using Onfi without first consulting their doctor. Discontinuing use of Onfi suddenly can cause severe withdrawal problems, such as seizures, hallucinations, shaking, nervousness, and stomach or muscle cramps.

Do I Have an Onfi Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Onfi lawsuits. We are handling individual litigation nationwide and currently accepting new Onfi Stevens-Johnson syndrome and toxic epidermal necrolysis cases in all 50 states.

Free Onfi Lawsuit Evaluation: If you or a loved one developed Stevens-Johnson syndrome or toxic epidermal necrolysis after taking Onfi, you should contact our law firm immediately. You may be entitled to compensation by filing an Onfi suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition